| 000 | 01034 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250515035556.0 | ||
| 264 | 0 | _c20061030 | |
| 008 | 200610s 0 0 fre d | ||
| 022 | _a0370-629X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKrzesinski, J M | |
| 245 | 0 | 0 |
_a[Angiotensin converting enzyme inhibitors or angiotensin II receptor blocker in cardiovascular and renal pathology in 2006: what does EBM teach us?]. _h[electronic resource] |
| 260 |
_bRevue medicale de Liege _c |
||
| 300 |
_a414-22 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Review | ||
| 650 | 0 | 4 | _aAngiotensin II Type 2 Receptor Blockers |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xprevention & control |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Diseases _xprevention & control |
| 700 | 1 | _aMontrieux, Ch | |
| 700 | 1 | _aScheen, A J | |
| 773 | 0 |
_tRevue medicale de Liege _gvol. 61 _gno. 5-6 _gp. 414-22 |
|
| 999 |
_c16497543 _d16497543 |
||